Cudraxanthone L exhibits significant anti-inflammatory activity by inhibiting the production of nitric oxide (NO) in lipopolysaccharide (LPS)-stimulated microglial cells, suggesting potential use in managing neuroinflammatory conditions. It also demonstrates moderate cytotoxic effects against certain human cancer cell lines, indicating possible applications in anticancer research. Additionally, its antioxidant properties may contribute to cellular protection against oxidative stress, supporting its role in developing therapies for degenerative diseases. Studies continue to explore its bioactive potential in pharmaceutical contexts.